Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Dundee Corp T.DC.A

Alternate Symbol(s):  DDEJF

Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include mining investments, mining services, and corporate and others. Its asset base includes investments in precious and base metals projects across four continents. Its subsidiaries include Dundee Sustainable Technologies Inc. (Dundee Technologies), Dundee Resources Limited, and Goodman & Company, Investment Counsel Inc. The Dundee Sustainable Technologies Inc., a 78%-owned subsidiary developing patented sustainable precious and base metals extraction processes. Through the development of its patented processes, the GlassLock Process and the CLEVR Process, Dundee Technologies extracts precious and base metals from ores and concentrates, while stabilizing contaminants such as arsenic.


TSX:DC.A - Post by User

Comment by TheCount11on Mar 14, 2024 9:04pm
114 Views
Post# 35934039

RE:RE:RE:RE:RE:RE:UOB KayHian on Genting/Taurx

RE:RE:RE:RE:RE:RE:UOB KayHian on Genting/TaurxHey Mac know everything there is to know about AD, treatments (ease of use, benefit vs risk) and total costs. 

What were the revenues for Donepezil (Aricept), Rivastigmine (Exelon) and Galantamine (Razadyne) in 2009?

What were the expected peak annual revenues for Aducanumab (Aduhelm)?
What happed to Aduhelm?

When your doctor (GP) is taking your blood pressure ask them how they FEEL about treating AD.  Ask them if patients would prefer a pill or intravenous (IV) that is delivered every two weeks.
What about side effects when comparing options?

Then lets talk about value of TauRx as I could be too much of a believer in the 2 year results just published.

PS I am not asking you to do anything I have not already done : )
<< Previous
Bullboard Posts
Next >>